pharma news

News

J&J abandons Alzheimer's antibody in setback for tau

Hopes that anti-tau drugs could emerge as treatments for Alzheimer's have been dented by the failure of a phase 2b trial of J&J's posdinemab.

News

Lilly becomes first $1trn+ pharma company

Eli Lilly has become the first pharma group to reach a value of more than $1 trillion, joining a select group populated mainly by tech giants.

News

Overweight man leans on office desk with female co-worker

Waltz dances into direct-to-employer sales of obesity drugs

Waltz Health is planning to disrupt the weight-loss therapy market in the US with a new direct-to-employer sales channel.

News

Neuralink rival Paradromics cleared to start speech trial

Brain computer interface developer Paradromics has been cleared to start a US clinical trial of its Connexus implant for speech restoration.

News

Alnylam's ATTR cardiomyopathy drug backed for NHS use

Patients with ATTR-CM in England and Wales will soon have a new treatment option, after NICE backed use of Alnylam's three-month injectable Amvuttra.

News

ADC specialist Solve raises $120m, and other biofinancings

Our round-up of biofinancings is led by a $120m round for ADC specialist Solve, with Aspen, Artios, Profluent, and Gate Bioscience also raising funds.

J&J abandons Alzheimer's antibody in setback for tau

Lilly becomes first $1trn+ pharma company

Waltz dances into direct-to-employer sales of obesity drugs

Neuralink rival Paradromics cleared to start speech trial

Alnylam's ATTR cardiomyopathy drug backed for NHS use

ADC specialist Solve raises $120m, and other biofinancings

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks